$ Value
$68K
Shares
1,327
Price
$51
Filed
Jul 28
Insider
Name
Assis Alessandra Faccin
Title
SVP and GM, Life Sciences
CIK
0001931500
Roles
Transaction Details
Transaction Date
2025-07-25
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
4,946
Footnotes
Balance includes additional restricted stock units acquired in lieu of cash dividends. | Payment of tax liability by withholding securities incident to the vesting of Restricted Stock Units acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. | Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. | On July 25, 2024, the Reporting Person was granted 15,234 restricted stock units, vesting over a three-year period, with 20% vesting on July 25, 2025, 20% vesting on July 25, 2026, and 60% vesting on July 25, 2027, provided that the Reporting Person remains in continuous employment with the Issuer.
Filing Info
Assis Alessandra Faccin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-19 | ASH | A | $0 |
| 2025-11-19 | ASH | A | $0 |
| 2025-11-13 | ASH | M | $71K |
| 2025-11-13 | ASH | F | $30K |
| 2025-11-13 | ASH | M | $0 |
| 2025-07-25 | ASH | M | $160K |
| 2025-07-25 | ASH | F | $68K |
| 2025-07-25 | ASH | M | $0 |
Other Insiders at ASH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
NOVO GUILLERMO
Chair of the Board and CEO
|
— | — | 2026-02-06 |
| Bishop Steven D | — | — | 2026-03-31 |
| Chattopadhyay Sanat | — | — | 2026-03-31 |